GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Seattle Genetics, Inc. (SGEN) [hlAlert]

Seatlle Genetic develops monoclonal antibody-based drugs to treat cancer and related diseases. Using its monoclonal antibody-based technologies and its expertise in cancer, the company have assembled
a portfolio of drug candidates targeted to many types of human cancers. The company utilizes its monoclonal antibody-based technologies to increase the potency and efficacy of antibodies with specificity for cancer. The company is testing our two most advanced product candidates, SGN-15 and SGN-10, in patients with breast, colon, prostate or other cancers.
( Total: 22 Current Stock Recommendations )
Seattle Genetics, Inc.   (22)
Sell 32% Hold 23% Buy 45%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
11/9/2012  
Hold
  
2/24/2014  
Sell
  
10/5/2011  
Sell
  
11/2/2010  
Sell
  
3/9/2011  
Sell
  
8/4/2010  
Sell
  
1/6/2011  
Buy
  
2/13/2013  
Hold
  
9/21/2007  
Buy
  
10/15/2009  
Hold
  
8/21/2007  
Buy
  
10/24/2007  
Buy
  
10/7/2008  
Hold
  
8/1/2013  
Sell
  
9/14/2015  
Buy
  
9/7/2012  
Buy
  
1/28/2008  
Buy
  
7/9/2014  
Buy
  
8/12/2009  
Buy
  
11/13/2012  
Buy
  
11/1/2010  
Sell
  
4/30/2008  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy